Regulatory
NDA
New Drug Application — the FDA submission requesting approval to market a drug.
Definition
An NDA includes complete clinical trial data, manufacturing specifications, and proposed labeling. Approval typically requires Phase 3 efficacy and safety data. Biologics use a parallel BLA (Biologics License Application) process.
Related terms
Back to the full peptide glossary.